Category Archives: News

GoodVets Announces Strategic Growth Investment from General Atlantic to Fuel Continued Expansion of Leading Veterinary Care Platform

September 13, 2023 – Chicago, IL – GoodVets Group LLC (“GoodVets”), a leading modern, single-brand veterinary care platform purpose-built to better serve pet owners and vets through premier medicine, customer service, technology, and design, today announced it has received a strategic growth investment from General Atlantic, a leading global growth equity firm. General Atlantic joins existing investor SkyKnight Capital, L.P. (“SkyKnight”).

Founded in 2016, GoodVets partners with entrepreneurial veterinarians to build and operate state-of-the-art care facilities in fast-growing markets, elevating the veterinary healthcare experience by bringing convenient, superior care closer to home. The Company’s mission is to reimagine today’s companion animal care experience, empower veterinarians to have autonomy and buy-in as participating owners, and deliver a wonderful healthcare experience for pets.

Under GoodVets’ leadership, veterinarians act as local hospital owners while benefitting from GoodVets’ centralized resources and support, including employee training, career development, attractive compensation packages, marketing, and industry-leading technology. General Atlantic has committed strategic resources and capital to help GoodVets accelerate its de novo strategy and achieve its goal of building the premier national provider of general and urgent veterinary care services.

GoodVets currently operates 22 care centers in 11 metropolitan areas, including Chicago, Atlanta, Miami, Tampa, Nashville, Charlotte, and Denver, with new sites planned to open in New York City, Los Angeles, and Dallas in the coming months.

Ryan Joseph, Co-Founder and CEO of GoodVets, said, “This collaboration not only validates our unwavering commitment to the betterment of veterinary care but also signifies a momentous leap forward in achieving our mission. With General Atlantic by our side, we are equipped with the financial strength, expertise, and global network to empower veterinarians nationwide. Together, along with SkyKnight’s steadfast support, we will continue to innovate, create, and drive the transformation of the veterinary industry, ultimately improving the lives of animals and the professionals who care for them.”

“GoodVets has emerged as a leader in the de novo veterinary market, taking a fresh approach and offering an excellent experience for pets, pet parents, and veterinarians,” commented Andrew Ferrer, Managing Director at General Atlantic. “We are excited to partner with Ryan and the team to continue to accelerate GoodVets’ growth and build a scaled national veterinary platform in the years to come.”

“Having spent multiple years focused on the veterinary market, we have been highly impressed with GoodVets’ strategy and differentiation,” added Ben Sherman, Vice President at General Atlantic. “General Atlantic shares GoodVets’ commitment to empowering entrepreneurship, and we look forward to helping the company bring this partnership approach to new locations around the country.”

Jordan Milich, Partner at SkyKnight Capital, said, “GoodVets pioneered a unique partnership approach with veterinarian owners – a strategy that mirrors SkyKnight’s core philosophy of ownership alignment with entrepreneurs. General Atlantic shares this foundational belief, and we are thrilled to collectively support GoodVets in building the industry-defining company in veterinary care.”

Jefferies LLC served as exclusive financial advisor and Holland & Knight LLP served as legal advisor to GoodVets. Piper Sandler & Co. served as financial advisor and Paul Weiss served as legal advisor to General Atlantic.

About GoodVets

GoodVets is a veterinary care platform providing elevated pet healthcare in beautifully designed, newly built spaces for today’s pet community. GoodVets partners with entrepreneurial veterinarians who want to own and lead their own practices and redefine the veterinary care experience for their communities. GoodVets hospitals prioritize wellness, prevention, and urgent care. More information is available at www.goodvets.com.

About General Atlantic

General Atlantic is a leading global growth equity firm with more than four decades of experience providing capital and strategic support for over 500 growth companies throughout its history. Established in 1980 to partner with visionary entrepreneurs and deliver lasting impact, the firm combines a collaborative global approach, sector specific expertise, a long-term investment horizon and a deep understanding of growth drivers to partner with great entrepreneurs and management teams to scale innovative businesses around the world. General Atlantic has more than $77 billion in assets under management inclusive of all products as of June 30, 2023, and more than 220 investment professionals based in New York, Amsterdam, Beijing, Hong Kong, Jakarta, London, Mexico City, Miami, Mumbai, Munich, San Francisco, São Paulo, Shanghai, Singapore, Stamford and Tel Aviv. For more information on General Atlantic, please visit: www.generalatlantic.com.

About SkyKnight Capital

Founded in 2015, SkyKnight Capital manages over $3 billion in private equity capital on behalf of leading institutional family offices, foundations, endowments, and pensions. SkyKnight makes long-term investments into high quality businesses in acyclical growth sectors alongside exceptional management teams. SkyKnight aims to build industry defining businesses in healthcare, financial services, and tech-enabled services. More information is available at www.skyknightcapital.com.

Media Contacts

David Saginur
GoodVetsdavid@goodvets.com

Emily Japlon
General Atlanticmedia@generalatlantic.com

Mara Hunt
SkyKnight Capitalmara@skyknightcapital.com

Categories: News

Tags:

Rojo Consultancy acquisition

365 Capital

Rojo Consultancy and 365 Capital announce their new partnership to accelerate the company’s growth as the preferred global partner for SAP integration.

‍Rojo Consultancy (“Rojo”) is a leading and trusted provider of consultancy services, managed solutions, and software for SAP integration and business process observability. Rojo has a strong position in the system integration software market and offers its clients a 360-degree portfolio of services to streamline their application integration needs and help their businesses grow. The company was established in 2011 and has evolved over the past decade from a consulting firm to an end-to-end SAP integration specialist. Rojo has a wide range of services and strategic partnerships with leading software vendors such as SAP, Coupa, SnapLogic, and Splunk. Rojo is headquartered in the Netherlands and operates globally from its offices in the Netherlands, Spain, and India.

Rojo has entered into a strategic partnership with 365 Capital to achieve its goals of being the preferred partner of choice, catering to market needs, and improving its ability to offer value-driven enterprise integration solutions to clients. As a result of this collaboration, Rojo intends to recruit new talent, invest in innovative integration software and enhance its global presence to meet the increasing demand from its clients. This partnership demonstrates Rojo’s dedication to providing exceptional service and value to customers while progressing its market expansion and success.

Roberto Viana (Managing director and co-founder): “At Rojo, we take great pride in the fantastic company we have established together with our team, strategic partners and global clients. Hence, joining forces with 365 Capital sets an important milestone for our team, clients and partners that will allow us to accelerate and expand the growth of Rojo. This collaboration will enable us to accelerate and expand the further growth of Rojo, and we couldn’t be more excited about the new opportunities that lie ahead. Our fixation and commitment to deliver high quality in everything we do for our clients’ business objectives remain steadfast. By partnering with 365 Capital, Rojo is set to reach new heights in helping clients achieve their business goals through high-quality enterprise integration solutions from Rojo.”

Reinaert Molenaar (Partner at 365 Capital): “We are very excited about the partnership with Rojo Consultancy. We are impressed with the company as it is today, and we look forward to supporting management and the rest of the Rojo Consultancy team to bring the company to the next level. Rojo is perfectly positioned to capitalise on several market tailwinds we see in the sector, with the right people and culture, a strong technological base and diversified end market exposure.”

Categories: News

Tags:

Online print production house Probo is strengthening its shareholder base with investor NPM Capital | NPM Capital

NPM Capital

Online print production house Probo is strengthening its shareholder base with investor NPM Capital | NPM Capital

Probo has reached an agreement with the Dutch investment company NPM Capital to join its shareholder base. Probo, founded in 2001 and located in Dokkum, has grown into one of the largest and most innovative printing and fulfilment partners for resellers, with more than 25,000 m² of production space and 600 (400fte) employees. Probo wants to execute its strategic growth plans with support of NPM Capital.

Probo offers a unique online platform allowing print professionals to order customised printed products, such as banners, flags, stickers, posters, wall decorations and textiles. De Hoge Dennen Capital came on board as a shareholder in 2017, after which the company experienced significant growth. This was a direct result of a continuous focus on operational efficiency, innovation and a customer-oriented approach. Probo’s management team intends to accelerate the development of its success and growth by adding NPM Capital to the shareholder base.

The next step towards strategic growth
“NPM will allow us to take the next step in our strategic growth plans. This is a fantastic development for Probo and in particular for our resellers and employees,” according to Leon van der Meer, Probo’s Managing Director. “Probo has been industry leading for years and we have recently achieved a market leading position in our home market. We will continue investing in our services, logistics, sustainability and, of course, new printing products, technologies and finishes in order to maintain this position.”
Innovative capacity and focus on sustainability
Martijn Koster, Investment Director at NPM Capital: “Probo’s digital platform perfectly fits into our ‘Everything is Digital’ strategic investment theme. We view Probo’s focus on innovation, sustainability and automated B2B resellermodel as strong assets for the company’s continued growth and development. We’re certainly also impressed by the employees’ knowledge, skills and commitment and look forward to driving the company’s growth together with them.”

The intended transaction is subject to approval from the Netherlands Authority for Consumers and Markets (Autoriteit Consument & Markt).

 

Categories: News

Tags:

Nordic Capital-backed iLOQ expands to Australia

Nordic Capital

iLOQ, a provider of digital access management solutions, will continue to fulfil its growth strategy by expanding to Australia.

Founded in Finland in 2003, iLOQ currently has sales offices in thirteen countries in Europe, the Middle East, USA and Canada, as well as a comprehensive global partner network. Starting operations in Australia will advance iLOQ’s growth strategy and open up a large new market for the company.

Mike Smits has been appointed Country Manager, iLOQ Australia, from the beginning of September. His role is to develop the Group’s business into new markets and business models by launching operations in Australia and building a local country organization. He is also responsible for leading the smart-locking revolution as iLOQ expands to a new continent.

Before joining iLOQ, Mr Smits held senior management roles in multinational companies such as Honeywell, VACON and Danfoss. He also brings a wealth of market experience from the Asia Pacific region.

“iLOQ continues to grow in line with its strategy. We bring to new markets state-of-the-art digital- and mobile-based locking solutions that are flexible, sustainable and reduce lifecycle costs,” said Heikki Hiltunen, CEO of iLOQ.

 

For more information, please contact:

Heikki Hiltunen
President and CEO, iLOQ
e-mail: heikki.hiltunen@iloq.com

Thomas Thörewik
Chief Sales Officer, iLOQ
e-mail: thomas.thorewik@iloq.com

About iLOQ
iLOQ is a rapidly growing Finnish company that is leading the technological revolution in the digital locking industry. iLOQ transforms mechanical locks into digital and mobile access management. iLOQ solutions are based on technologies developed and patented by the company, enabling electronic and mobile locking without batteries or cables. iLOQ replaces mechanical and electromechanical locking systems with environmentally friendly solutions that solve the problems of lost or copied keys, reduce lock maintenance and minimise lifecycle costs. For more information about iLOQ, please see: www.iloq.com

Categories: News

Tags:

Thompson Street Capital Partners Announces the Sale of ZymeFlow to ShawKwei & Partners

Thompson

Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, MO, announced today it has completed the sale of ZymeFlow and its related group of companies to ShawKwei & Partners (ShawKwei), an Asian private equity industrial investor. Terms of the transaction were not disclosed.

Based in Houston, Texas, ZymeFlow’s ecofriendly and patented products and services are highly efficient in the decontamination and maintenance of chemical plants and energy refinery facilities in the US and around the world. ShawKwei purchased ZymeFlow in partnership with management from investors, including TSCP. The acquisition supports ShawKwei’s energy transition investment strategy of a lower carbon economy.

“Our collaboration with ZymeFlow’s leadership team enabled the company to strengthen its management team and enhance its products and services while maintaining the highest level of customer service,” said Harry Holiday, Managing Director at Thompson Street Capital Partners. “ZymeFlow is well positioned for both strategic and geographic expansion and we’re excited to see what the future holds.”

Founded more than 35 years ago, ZymeFlow provides customers with innovative solutions using proprietary advanced chemistries that are biodegradable, environmentally safe, and cost efficient. ZymeFlow owns patented products and engineering application methods including ZymeFlow®, Rezyd-H™, CatZyme RT™, and Vapour-Phase® together with service staff and equipment for the decontamination of process equipment in refineries, chemical plants, and industrial facilities. ZymeFlow products and application services are sold to both onshore and offshore energy and chemical customers in over 55 countries.

“Today there is an urgent need to use the safest and most effective ZymeFlow decontamination products and services that are 100% biodegradable, safe, non-toxic, and incredibly powerful,” said Tom McQuery, Founder and President of ZymeFlow. “ShawKwei is an experienced global investor in the energy transition industry and is committed to growing ZymeFlow in both the US and international markets. The ZymeFlow management team is excited to be part of the ShawKwei group of companies, and in combination with CR3’s capabilities ZymeFlow will be able to expand into an even larger combined customer base.”

Categories: News

Tags:

Yellowtail Conclusion adds fintech ADPI to its portfolio

NPM Capital

Joining forces for the most progressive consultancy platform

Yellowtail Conclusion has acquired ADPI, the innovative mortgage SaaS platform for lenders and intermediaries, from founder Maarten Tellegen and investor Beekers Capital. With the addition of the ADPI SaaS platform for mortgage orientation, consultancy, mediation and management, Yellowtail Conclusion has all the components for a digital and efficient mortgage process. From the first customer contact to active management.

Matthijs Mons, Managing Director of Yellowtail Conclusion: “With ADPI, together with our existing components, we now have by far the most modern, innovative and secure SaaS platform in the financial consultancy market. The combination of the innovative ADPI platform within the solid Yellowtail Conclusion environment is truly unique. This means our dream of developing the consultancy platform of the future is now very close.”

Maarten Tellegen, founder of ADPI: “Yellowtail Conclusion is the ideal acquisition partner for us. Yellowtail’s reach in the sector will accelerate ADPI’s growth in the market for intermediaries, service providers and lenders alike. In addition, Yellowtail’s professional organisation guarantees the stability and innovative power to continue to offer the most progressive software package in the market. A win-win situation for everyone involved.”

ADPI will be integrated into Yellowtail Conclusion and continue as Hypact Advisor. This makes ADPI part of the complete Hypact Suite, including Hypact, Online Advice, Hypact Hub and Hypact HypotheekAssist. This enables Yellowtail Conclusion to serve all parties in the mortgage chain, from independent consultant, via service provider to lender. Founder Maarten Tellegen and his team remain involved and Maarten will continue to manage the company in the future. The operational teams will work closely together to ensure a smooth transition. Existing ADPI customers can rest assured that their ongoing projects and contracts will continue without interruption.

The combination will benefit from maximum sector knowledge, an extensive talent pool and the synergies between the two companies will contribute to further innovation and growth.

 

 

Categories: News

Tags:

Main Capital Partners acquires Danish market leading industry-specific software provider Unik System Design

Main Capital Partners

Main Capital Partners is delighted to announce the signing of the acquisition of a majority stake in Unik System Design (‘Unik’).

Main Capital Partners (‘Main’) is delighted to announce the signing of the acquisition of a majority stake in Unik System Design (‘Unik’), a leading software vendor with deep industry and domain knowledge within housing- & property management and legal administration. Main will act as a strategic partner to the management team, supporting Unik in its ongoing journey towards becoming a leading pureplay Software-as-a-Service provider (‘SaaS’), underpinned by an international buy & build strategy.

Founded in 1985, Unik is an innovative Danish industry-specific software vendor with +240 employees and consultants in Vejle, Aalborg, Copenhagen and Warsaw. With close to four decades of experience, the company has positioned itself with the market’s most used software solutions, servicing more than 900 clients ranging from large scale private and public housing associations to law offices and legal corporate departments throughout Denmark.

Unik is in the state of re-inventing itself, not only to be able to provide a higher degree of efficiency, automation and digitalization to its daily users, but also to push the limits for what happens when digital innovation meets deep industry knowledge. Over the next couple of years, the two new SaaS products, HabiCen for housing- & property management, and JustiCase for legal administration, will gradually replace the current products, Unik Bolig og Unik Advosys.

Looking ahead, Main Capital Partners will actively support Unik in maintaining the strong growth momentum by further broadening the product offering to its existing customers. In addition to organic growth initiatives, strategic add-on acquisitions will be an important pillar of the strategy to complement the innovative product portfolio as well as to strengthen the market position, both in Denmark and abroad.

Jens Find, CEO of Unik System Design, comments: “We were not in the market for a partner, but in our dialogue with Main we realized the potential this partnership could bring to the table. After 38 years as CEO and main owner, it is my clear impression that it is the right decision for Unik, our customers and our employees. We will continue with the current management and the current owners will retain a significant ownership of 40%. For us it is more of a partnership than a sale.”

Tonni Rasmussen, CTO of Unik System Design, comments: “Our customers rely on our ability to innovate and leverage our industry expertise to establish the benchmark for how software can automate their business operations. Developing two cutting-edge SaaS-products, HabiCen and JustiCase, is part of the next big innovation of Unik, with focus on enhanced security and operational efficiency. I am convinced our strategic partnership with Main will further accelerate this transition, enabling us to expedite the delivery of the next generation Enterprise software solutions.”

Wessel Ploegmakers, Partner at Main Capital Partners, concludes: “Unik has been on our radar for a long time as one of the leading Danish software vendors, and we are pleased to be given the opportunity to support the company going forward in its journey to become an international leading SaaS-provider. We are confident that our focused organic growth initiatives coupled with a selective buy-and-build strategy will result in an improved value proposition towards existing and new customers.”

We are confident that our focused organic growth initiatives coupled with a selective buy-and-build strategy will result in an improved value proposition towards existing and new customers.

– Wessel Ploegmakers, Partner at Main Capital Partners

About

Unik System Design

Unik System Design is a Danish software company developing industry solutions for housing- & property management and legal administration, with more than 240 employees and consultants in Vejle, Aalborg, Copenhagen and Warsaw. Unik has over 35 years of experience in creating the most efficient digital workday for their customers, developing and supplying selected industries with the market’s most used software solutions.

Categories: News

Tags:

twig secures £3 million in funding to bioengineer eco-friendly products at scale

Seedcamp

Our planet’s natural resources are increasingly under strain due to climate change and overconsumption. Novel and more eco-friendly solutions to how we produce food and essential everyday items are urgently needed to sustain a growing global population.

This is why we are excited to back twig, a UK-based bioengineering company that harnesses an AI-first approach to develop eco-friendly alternatives to everyday ingredients in consumer goods, and replace environmentally harmful chemicals and ingredients (e.g. acetone, palm oil, or isoprene), which are typically produced from fossil fuels, or hyper-intensive farming.

Founded by Dr. Russ Tucker (who previously founded UK cultivated meat pioneer Ivy Farm), Dr. James Allen, and Dr. Satnam Surae, twig is on a mission to radically improve the speed and efficacy of lab-based bioengineering, creating affordable, scalable, and dependable ingredients that producers can use in the everyday items the world relies on.

Dr. Russ Tucker, co-founder of twig highlights: 

“Many of the biggest little ingredients that go into the products we use in our daily lives are hugely damaging for the planet. This needs to change, and this needs to happen fast. (…) through the right combination of  AI and automation, we can deliver a step-change in bioengineering, driving a global transition from unsustainably resourced ingredients to bio-fermented ingredients in a way that benefits everyone – people, producers, and the planet.” 

twig’s new approach fundamentally reduces the time and costs of conventional bioengineering processes for developing potential ingredient strains. Combining AI and SynBio (synthetic biology), twig relies on three distinct tech pillars:

1) Bio:Builder: a best-in-class biological tool that allows it to create the building blocks to develop its new sustainable ingredients.

2) Grow:Bot: a dependable, programmable, and scalable robotics, enabling the manipulating and analysis of tens of thousands of bacteria variations each month.

3) ML:Bridge: twig’s AI connects the dots across the ever-growing standardised and formatted data library generated by Bio:Builder and Grow:Bot. ML:Bridge reviews production yields against target thresholds and recommends pathway improvements.

Since its beginnings in late 2022, twig has already tested thousands of strains through their automated platform in just five short months in the lab.

On why we invested, our Partner Tom Wilson comments:

“We believe the timing is perfect for seeing a real breakthrough in bioengineered products due to advancements in AI and automation. The Twig team have the perfect combination of technical and domain expertise to make their vision a reality and we’re thrilled to have the opportunity to partner with them.“

We are excited to participate in twig’s £3 million seed round, alongside Project A, Zero Carbon Capital, UK Innovation and Science Seed Fund, Gaingels, and expert angels.

For more information, visit twig.bio.

Categories: News

Tags:

KKR Provides £75 million Financing Facility to TalkTalk

KKR

NEW YORK & LONDON–(BUSINESS WIRE)– KKR, a leading global investment firm, today announced that funds and accounts managed by its credit business have agreed to provide a £75 million non-recourse financing facility to TalkTalk, a leading value for money connectivity provider in the UK. The facility, which is collateralized by certain accounts receivables originated by TalkTalk and its subsidiaries, replaces a prior £75 million financing facility, which matures in September 2023.

The new facility will give TalkTalk access to additional liquidity for a term of approximately three years.

“We are pleased to use our experience in receivable financing globally to support TalkTalk with capital that will help the company continue to grow and connect consumers and businesses across the United Kingdom,” said Giacomo Picco, a Managing Director at KKR.

Demica served as advisor to TalkTalk and will act as the reporting and calculation agent for the program.

About KKR

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

About TalkTalk​ Group

TalkTalk is the UK’s leading value for money connectivity provider. It believes that simple, affordable, reliable and fair connectivity should be available to everyone.

From its HQ in Salford, TalkTalk is rolling out the UK’s latest fibre technology, bringing 100% full fibre directly into homes and businesses across Britain.

KKR Americas:
Julia Kosygina
+1 212-750-8300
Media@kkr.com

KKR EMEA:
Annabel Arthur
+44 20 7839 9800
kkrpr-uk@kkr.com

Source: KKR

Categories: News

Tags:

Jeito Capital co-leads eur 65 million (USD 71 MILLION) financing in Corteria Pharmaceuticals, a French Biopharmaceutical company

Jeito Capital
  • Jeito Capital co-leads oversubscribed financing
  • Corteria, a late preclinical stage company, is developing first-in-class therapies with promising novel approaches for unaddressed heart failure subpopulations, addressing high unmet medical needs
  • Jeito Capital marks its first investment in the cardiovascular space, further diversifying its strong portfolio

Paris, France, September 7th 2023 – Jeito Capital (“Jeito”), a global leading investment firm dedicated to healthcare and biopharma, announced today that it is co-leading a EUR 65m (USD 71m[1]) Series A financing round in Corteria Pharmaceuticals (“Corteria” or the “Company”), a biopharmaceutical company specialized in the development of transformative therapies for unaddressed heart failure subpopulations.

The oversubscribed financing was co-led by new investors Jeito and Orbimed, with participation from existing investors Kurma Partners, Fountain Healthcare Partners, V-Bio Ventures, Invivo Capital, and Omnes Capital.

Corteria was founded in 2021 by Sanofi’s former head of cardiovascular research, Philip Janiak and Marie-Laure Ozoux, former cardiovascular project leader at Sanofi, around two cardiovascular programs in-licensed from Sanofi[2].

Proceeds from the financing will be used to advance the Company’s heart failure pipeline into the clinic.

Since its inception, Corteria’s pipeline has expanded rapidly and comprises today three first-in-class therapies:

  • A once-daily subcutaneous CRF2[3] agonist for the treatment of Worsening Heart Failure. It is anticipated that Corteria will bring this lead asset, into clinical trials to validate the treatment pathway in early 2024.
  • A once-monthly subcutaneous CRF2[3] agonist, specifically developed for Right Heart Failure treatment. This compound also holds potential for broader applications in chronic cardiometabolic diseases, particularly those with coexisting conditions such as obesity and sarcopenia.
  • An AVP (arginine vasopressin) neutralizing monoclonal antibody for the treatment of Acute Heart Failure with Hyponatremia.

Jeito Capital has partnered with Corteria Pharmaceuticals, reflecting its vision to champion promising French and European biopharma companies with the potential to become global market leaders especially in Europe and the US. This collaboration marks Jeito’s first investment in the cardiovascular space, where emerging innovations and a supportive regulatory environment offer transformative potential for patient outcomes. Andreas Wallnoefer, Partner at Jeito Capital and with strong industry experience in the cardiovascular field, will join Corteria’s Board of Directors.

Dr. Rafaèle Tordjman, MD, PhD, Founder and CEO of Jeito Capital, commented: “With our first investment in the cardiovascular field, we are partnering with Corteria Pharmaceuticals, a French company with a global vision to address well-defined sub-populations of heart failure, with an urgent need for new and effective treatments. Corteria’s strong pipeline of assets, backed by a dedicated and highly experienced team with a proven track record in cardiovascular development, represents an exciting opportunity to expand treatment options. Their commitment to transformative therapies as a leading French biopharma with global aspirations perfectly aligns with Jeito’s mission, and we see great potential to make a meaningful difference in patient lives.”

Andreas Wallnoefer, Partner at Jeito Capital added: “Despite current treatments, heart failure is a progressing disease that impacts severely the lives of many patients and remains one of the leading causes of mortality worldwide. Corteria focuses on translating important therapeutic innovations in cardiology into clinical practice. Our investment in Corteria reflects Jeito’s commitment to address significant unmet needs in the realm of cardiology. We are excited to join forces with Corteria’s dedicated team to develop a portfolio of medicines with important clinical benefits for patients.”

“This financing marks a major milestone in our mission to bring therapies to heart failure subpopulations with high unmet needs,” said Philip Janiak, Founder and CEO of Corteria Pharmaceuticals. “We are extremely grateful to Jeito and OrbiMed as our new investors for their trust in our science and team and to our existing investors for their support and commitment since inception. We are looking forward to working all together to develop next generation transformative therapeutics.”

About Jeito Capital

Jeito Capital is a global leading Private Equity company with a patient benefit driven approach that finances and accelerates the development and growth of ground-breaking medical innovation. Jeito empowers and supports managers through its expert, integrated, multi-talented team and through the investment of significant capital to ensure the growth of companies, building market leaders in their respective therapeutic areas with accelerated patients’ access globally, especially in Europe and the United States. Jeito Capital has €534 million under management and a rapidly growing portfolio of investments. Jeito Capital is based in Paris with a presence in Europe and the United States.

For more information, please visit www.jeito.life or follow us on Twitter or LinkedIn.

About Corteria Pharmaceuticals

Founded in 2021, Corteria Pharmaceuticals is a privately held biopharmaceutical company developing first-in-class drugs in heart failure subpopulations. Despite some improvements in the management of this serious disease, the prevalence of heart failure keeps increasing with more than 60 million patients worldwide. Corteria’s strategy implies innovative patient stratification and target selection based on human evidence and a better understanding of the disease biology in patients with a focus on worsening and acute heart failure and right heart failure.

More information available at: www.corteriapharma.com

[1] Applying an 1.0886 EUR/USD exchange rate as of 30 August 2023 (Banque de France) rounded to $71m

[2] CRF2 peptide agonist and AVP neutralizing monoclonal antibody programs

[3] Corticotropin-releasing hormone receptor 2

For further information please contact:

Jeito Capital
Rafaèle Tordjman
Assia Mouhout, EA
assia@jeito.life
Tel: +33 6 76 49 37 94

Maior
Stéphanie Elbaz
stephanie.elbaz@maior-conseil.com
Tel: +33 6 46 05 08 07

Consilium Strategic Communications
Mary-Jane Elliott /
Davide Salvi / Kris Lam
Jeito@consilium-comms.com
Tél. : +44 (0) 20 3709 5700 

Categories: News

Tags: